LBX Pharmacy Chain JSC
SSE:603883
LBX Pharmacy Chain JSC
Cost of Revenue
LBX Pharmacy Chain JSC
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LBX Pharmacy Chain JSC
SSE:603883
|
Cost of Revenue
-¥15.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Cost of Revenue
-¥16.5B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Cost of Revenue
-¥4.8B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Cost of Revenue
-¥14.5B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Cost of Revenue
-¥6.6B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Cost of Revenue
-¥12.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
See Also
What is LBX Pharmacy Chain JSC's Cost of Revenue?
Cost of Revenue
-15.2B
CNY
Based on the financial report for Mar 31, 2024, LBX Pharmacy Chain JSC's Cost of Revenue amounts to -15.2B CNY.
What is LBX Pharmacy Chain JSC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-18%
Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for LBX Pharmacy Chain JSC have been -16% over the past three years , -18% over the past five years .